Corcept Therapeutics Incorporated shares owned by Martingale Asset Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Martingale Asset Management
from 13F filings
Historical chart of Martingale Asset Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Corcept Therapeutics Incorporated by Martingale Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.2M | 69k | 32.48 |
2023-09-30 | $1.9M | 69k | 27.25 |
2023-06-30 | $1.8M | 79k | 22.25 |
2023-03-31 | $1.6M | 75k | 21.66 |
2022-12-31 | $1.5M | 74k | 20.31 |
2022-09-30 | $1.8M | 71k | 25.65 |
2022-06-30 | $1.7M | 71k | 23.78 |
2022-03-31 | $310k | 14k | 22.59 |
2021-12-31 | $1.3M | 67k | 19.81 |
2021-09-30 | $1.3M | 65k | 19.69 |
More positions owned by Martingale Asset Management
View all positions for Martingale Asset Management
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated